Figure 2
Stratification by age groups of anti-Xa, aPTT, and ACT values (median, 95% CI) in samples after UFH administration comparing dose groups (high-dose vs low-dose).
Stratification by age groups of anti-Xa, aPTT, and ACT values (median, 95% CI) in samples after UFH administration comparing dose groups (high-dose vs low-dose).
